Miguel Cervero
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 8
- COVID-19 Clinical Research Studies 5
- Emergency Medicine top 10%
- HIV-related health complications and treatments 11
- Virology top 10%
- HIV Research and Treatment 8
-
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- Vitamin D Research Studies 4
-
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- Rafael TorresMaría VelascoCarlos BarrósJosé SanzEmilia CondésG. GasparVictoria AlcázarCarlos Guijarro
- Partner nations
- SpainUnited StatesPalestinian Territory
In The Last Decade
Miguel Cervero
40 papers receiving 320 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 191
- Emergency Medicine 87
- Virology 34
- Epidemiology 135
- Pathology and Forensic Medicine 70
Countries citing papers authored by Miguel Cervero
This map shows the geographic impact of Miguel Cervero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Cervero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Cervero more than expected).
Fields of papers citing papers by Miguel Cervero
This network shows the impact of papers produced by Miguel Cervero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Cervero. The network helps show where Miguel Cervero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miguel Cervero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 25 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 2 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 14 | |
| 14 | 2016 | 6 | |
| 15 | 2015 | 2 | |
| 16 | 2012 | 37 | |
| 17 | 2010 | 1 | |
| 18 | 2008 | 11 | |
| 19 | 2007 | 9 | |
| 20 | 2000 | 6 |
About Miguel Cervero
Miguel Cervero is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 44 papers that have together received 325 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (11 papers), HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers), COVID-19 Clinical Research Studies (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Vitamin D Research Studies (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). The work is most often cited by research in Infectious Diseases (191 citations), Emergency Medicine (87 citations) and Virology (34 citations). Miguel Cervero has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include Rafael Torres, María Velasco, Carlos Barrós, José Sanz, Emilia Condés, G. Gaspar, Victoria Alcázar, Carlos Guijarro, Santiago Moreno and Montserrat Torres. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.